Abbott Laboratories’ diagnostics and vascular businesses witnessed increased revenues in the first quarter of 2010, carrying on a good performance from the units at the start of 2010. The firm’s diagnostics sales were $915m, up 12% on a reported basis compared to the same period last ...
Clinica
Abbott sees solid medtech growth but cuts outlook
21 April 2010
Joseph Harvey
Not a subscriber ? Request a FREE Trial
Subscribe to Clinica
RELATED CONTENT
NEWS
Clinica News
- Quarterly round-up: Boston swings to profit; Edwards boosted by Sapien sales
- Quarterly results round-up: “no better, no worse” for Bard, Roche suffers from exchange rates again
- Quarterly results round-up: Covidien shows strong start, Recon still weak but other units give boost to Zimmer and Stryker
- Quarterly results round-up: Abbott staying conservativelyoptimistic, Quest and St Jude see profits fall
Other Informa News
Features & Analysis
Other Informa Analysis
EVENTS
19 March 2012
Montreux Convention and Music Centre, Switzerland
